LuminiCell
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LuminiCell - overview
Established
2014
Location
Singapore, -, Singapore
Primary Industry
Biotechnology
About
Based in Singapore, and co-founded in 2014 by Bin Liu, and Luda Kopeikina (CEO), LuminiCell, aka Luminicell Pte Ltd, operates as a biotechnology company that develops, manufactures, and offers fluorescent nanoparticles to biotechnology and pharmaceutical firms looking to expand their research capabilities, track biological processes and conduct long-term imaging research on biological systems. LuminiCell provides imaging tools and fluorescent nanoparticles for biological research. The firm product portfolio includes cellular trackers, vascular trackers, AIE photosensitizers, and antibody conjugates which help in tracking the biological processes required for research in biotechnology and pharmaceutical verticals. The company also provides services such as providing unprecedented AIE conjugates, making microfluidic/millifluidic mixers, and developing AIE dots for lateral flow experiments.
Current Investors
SEEDS Capital, AITventures Pte Ltd
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.luminicell.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.